Specific inhibitor for toxic protein granzyme M of human immune system, preparation method and application
A technology of inhibitors and uses, applied in the field of new human immune system toxic protein granzyme M inhibitors
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] Synthesis, purification and identification of the compound of embodiment 1 formula (I)
[0028] The synthesis of the amino acid sequence Lys-Val-Pro-Leu in the compound of formula (I) can be carried out according to the solid phase synthesis technique known to those skilled in the art (for example, refer to "Solid Phase Organic Synthesis-Principles and Application Guidelines, edited by Wang Dexin, Chemical Industry Press, September 2004"). The acetylation modification of the N-terminal of the peptide and the CMK modification of the C-terminal are also known to those skilled in the art (Bell et al., 2003; Marzo et al., 1998).
[0029] The synthesis of the compound of formula (I) was entrusted to Hangzhou Zhongpei Biochemical Co., Ltd., and the results of synthesis, purification and identification can be found in figure 1 and 2 , wherein the modified peptide is separated and purified by C18 hydrophobic chromatography, and the obtained peptide is identified by mass spect...
Embodiment 2
[0032] The compound of embodiment 2 formula (I) inhibits the activity of human granzyme M
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com